Abbott Laboratories on Wednesday forecast 2025 profit that came in line with Wall Street estimates as it expects new device ...

The Texas A&M Forest Service said dry conditions paired with high winds and low temperatures are contributing to increased ...

It's the start of a new year, and that makes now the perfect time to load up on stocks that could boost your portfolio in 2025 and over the long term. The healthcare space is a great place to look for ...

Intuitive is buying businesses that distribute its da Vinci and Ion surgical robots to establish a direct presence in Italy, ...

"Seeing is believing," the founder of lab company Truvian told me. So I tried its tabletop blood testing device—which promises results in 30 minutes—for myself.

A number of bird flu cases have been reported in the Chicago area in recent weeks, leading to many questions about how quickly the virus is spreading and how worried residents should be.

Abbott's Q4 sales grow 7.2%, missing estimates, but analysts remain upbeat with strong 2025 projections driven by Diabetes ...

Analyst Lee Hambright of Bernstein maintained a Buy rating on Abbott Laboratories (ABT – Research Report), boosting the price target to ...

Stifel raised the firm’s price target on Abbott (ABT) to $135 from $130 and keeps a Buy rating on the shares. The firm views Abbott’s Q4 ...

Abbott Laboratories just extended its dividend growth streak with a 7.3% hike in the quarterly dividend per share last month.

C.R. Bard and its affiliates — Liberator Medical Supply, Liberator Holdings and Rochester Medical Corporation — agreed to pay $17 million to resolve allegations they provided kickbacks to physician ...

Abbott India Ltd. key Products/Revenue Segments include Pharmaceuticals, Other Operating Revenue, Scrap and Export Incentives for the year ending 31-Mar-2024.For the quarter ended 30-09-2024, the ...